Aspirin Management Before Elective Surgery
For most elective noncardiac surgeries, aspirin does NOT need to be stopped and should be continued perioperatively, particularly in patients with cardiovascular disease. However, when aspirin must be discontinued for high-bleeding-risk procedures, stop it 5-7 days before surgery (ideally stopping 7 days before, with surgery on day 6-8).
Risk-Stratified Approach
Continue Aspirin Through Surgery (Preferred)
Continue aspirin perioperatively for:
- Patients with moderate-to-high cardiovascular risk 1, 2
- Most noncardiac surgeries where bleeding risk is manageable 1, 3
- All patients undergoing CABG surgery 4, 5
- Minor procedures (dental, dermatologic, cataract surgery) 1
The 2012 ACCP guidelines and 2022 updated guidelines support continuation in patients at moderate-to-high cardiovascular risk, as the thrombotic risk outweighs bleeding concerns in most surgical contexts 1, 2.
Stop Aspirin Only for High-Bleeding-Risk Procedures
Discontinue aspirin 5-7 days preoperatively for:
- Intracranial surgery
- Spinal surgery
- Other ultra-high bleeding risk procedures where even modest bleeding could be catastrophic 6, 2
The specific timing: Stop aspirin ≤7 days before surgery (not the traditional 7-10 days), with most guidelines recommending 5 days as adequate 1, 2, 7.
Evidence Supporting Shorter Duration
Platelet function studies demonstrate that:
- Bleeding time normalizes within 96 hours (4 days) after aspirin cessation 7
- Platelet aggregation recovers within 3-6 days in most patients 7, 8, 9
- Surgery can safely proceed on day 6 after stopping aspirin 7
The 2022 ACCP guidelines explicitly recommend stopping aspirin ≤7 days (not 7-10 days) when interruption is necessary, reflecting this updated evidence 2.
Special Populations
Patients with Coronary Stents
- Continue aspirin regardless of timing from stent placement 4, 3
- If on dual antiplatelet therapy (DAPT), stop the P2Y12 inhibitor (clopidogrel/ticagrelor at 5 days, prasugrel at 7 days) but continue aspirin 4, 6
- Never stop both antiplatelet agents—median time to stent thrombosis is only 7 days when both are held versus 122 days when aspirin is continued 6
CABG Surgery
- Continue aspirin perioperatively 4, 5, 2
- Aspirin reduces perioperative myocardial infarction in CABG without significantly increasing mortality or reoperation rates 5
- The ATACAS trial (2,100 patients) showed no increased bleeding with continued aspirin 5
Low Cardiovascular Risk Patients
For patients taking aspirin for primary prevention only (low cardiovascular risk):
- Stopping 7-10 days before surgery is reasonable 1
- The POISE-2 trial showed no cardiovascular benefit but increased bleeding with aspirin continuation in this population 3, 10
Resumption After Surgery
Restart aspirin within 24 hours postoperatively once adequate hemostasis is achieved 4, 2. Earlier resumption (within 24 hours) is preferred to minimize thrombotic risk, particularly in patients with cardiovascular disease or coronary stents.
Critical Pitfalls to Avoid
Do not routinely stop aspirin for all surgeries—this outdated practice increases cardiovascular events without clear benefit 1, 2
Never stop aspirin in patients with recent coronary stents (especially <6 months for drug-eluting stents)—the stent thrombosis risk is catastrophic 3, 11
Do not stop aspirin 10 days before surgery—5-7 days is sufficient based on platelet recovery kinetics, and longer interruption unnecessarily increases thrombotic risk 2, 7
Do not use heparin bridging for aspirin—this increases bleeding without reducing thrombotic events 5